MOMA Therapeutics · Pricing Plans
Moma Therapeutics Plans Pricing
Moma Therapeutics Plans Pricing is the pricing profile for MOMA Therapeutics on the APIs.io network.
No plan was found on the pages read; the profile records that absence rather than inventing a tier.
Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Oncology.
0 Plans
Transcribed from the provider's pricing page on 2026-08-26 — momatx.com/.
View Source
CompanyBiotechnologyPharmaceuticalsDrug DiscoveryOncologyPrecision MedicineLife SciencesStructural BiologyMachine Learningcontent-api
Plans
No plan was found on the pages read; the profile records that absence rather than inventing a tier.
MOMA Therapeutics sells no API and publishes no pricing of any kind. It is a private clinical-stage biotechnology company whose revenue comes from partnership economics — a reported $66 million upfront plus milestones from the Roche discovery collaboration announced January 2024, and a collaboration and licence agreement with Bayer signed October 2024 — not from a product catalogue. There is no pricing page, no plans page, no billing surface and no "contact sales" API tier on momatx.com; the nav is Science, Pipeline, MOMA, Team, News & Publications and Join Us. The WordPress content API catalogued in this repository is a by-product of the corporate website, offered under no commercial terms at all. plan_count: 0 is the accurate measurement, not a gap in the search.
Work with this as data
Every plan here is available over the APIs.io API and to AI agents over MCP.